Ȩ > ´ÚÅÍÇÏÆ®¼Ò½Ä

 
¾È³çÇϽʴϱî? ´ÚÅÍÇÏÆ®¿¡¼­ °øÁö»çÇ×À» ¾Ë·Áµå¸³´Ï´Ù.
 
2024. 03. 29.
 Á¦12Â÷ ±¹Á¦ÀÌÁ¾À̽ÄÇÐȸ
±Û¾´ÀÌ: °ü¸®ÀÚ  ³¯Â¥: 2013.11.14. 11:32:57   Á¶È¸: 4198
2013³â 11¿ù 10ÀÏ~13ÀϱîÁö ÀϺ» ¿À»çÄ«, ¿À»çÄ«±¹Á¦È¸ÀÇÀå¿¡¼­ Á¦12Â÷ ±¹Á¦ÀÌÁ¾À̽ÄÇÐȸ Çмú´ëȸ°¡ ¼ºÈ²¸® °³ÃֵǾú´Ù.
Âü°¡ÀÚµéÀº Àü¼¼°è¸¦ Æ÷ÇÔÇÏ¿© ¹Ì±¹, À¯·´, È£ÁÖ, ´ºÁú¶õµå, Áß±¹, ÀϺ», Çѱ¹µî¿¡¼­ ¾à 400 ¿©¸íÀÇ ÀÌÁ¾À̽Ŀ¬±¸ °ü·ÃÇÐÀÚµéÀÌ 4ÀÏ°£ 400 ¿©ÆíÀÇ ÀÌÁ¾À̽İü·Ã ¿¬±¸¹ßÇ¥¿Í Ư°­, ½ÉÆ÷Áö¿òµîÀ¸·Î ¿­¶í Çмú´ëȸ°¡ ÁøÇàµÇ¾ú´Ù.
Çѱ¹¿¡¼­µµ ¿©·¯´ëÇп¡¼­ ¸¹Àº ¿¬±¸ÁøÀÌ Âü¼®ÇÏ¿´À¸¸ç ÃÊû°­¿¬, ¿¬±¸¹ßÇ¥¸¦ ½ÃÇàÇÏ¿´´Ù. ƯÈ÷ ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿¬±¸ÁøÀÌ Çѱ¹ ´ëÇ¥µéÀÇ ÁÖ·ù¸¦ ÀÌ·ç°í ÃÊû°­ÀÇ, ÁÂÀå, ½Ê¿©ÆíÀÇ ¿¬±¸°á°ú¸¦ ¹ßÇ¥ÇÏ¿´´Ù. ¼­¿ï´ëÇб³º´¿ø ÈäºÎ¿Ü°ú¿¡¼­µµ  Development of novel combined anticalcification protocol including immunologic modification for prolonged durability of cardiac xenograft in animal study¿Í In-vivo efficacy for treatment with decellularization, alpha-galactosidase, spacefiller, organic solvent and detoxifixation of GA-fixed cardiac xenograft using alpha-gal mouse implantation model À̶õ ¿¬Á¦¸¦ ¹ßÇ¥ÇÏ¿´´Ù. ±Ý³â¿¡´Â alpha-gal KO pig¿¡ genetic modification ÁøÇàÀÌ ´õ¿í ÇöÀúÇÏ°í, genetically induced disease(agenesis) model°³¹ß, chimerism ¹æ¹ýµµ ´«ºÎ½Ã°Ô ¹ßÀüµÇ¾ú´Ù. Çѱ¹µµ ÀÌ·¯ÇÑ ÀÌÁ¾À̽Ŀ¡¼­ À¯ÀüÀÚ Ã³¸® ±â¼úµéÀÌ »¡¸® Çâ»óµÇ±æ ±â¿øÇÑ´Ù.
LIST  MODIFY DELETE WRITE  





Àüü±Û ¸ñ·Ï 2024. 03. 29.  Àüü±Û: 211  ¹æ¹®¼ö: 1016329
153 Ä¯º¸µð¾Æ ½ÉÀå¼ö¼úÁö¿ø °ü¸®ÀÚ2015.09.07.3566
152 Á¦95Â÷ ¹Ì±¹ÈäºÎ¿Ü°úÇÐȸ(AATS) Annual Meeting °ü¸®ÀÚ2015.05.04.4161
151  Á¦51Â÷ STS Annual Meeting °ü¸®ÀÚ2015.02.02.3951
150 Àεµ³×½Ã¾Æ ¼ö¶ó¹Ù¾ß Dr. Seotomoº´¿ø °ø°øÀÇ·áºÀ»ç °ü¸®ÀÚ2014.11.10.4609
149 Áß±¹ Èæ·æ°­¼º ÇϾóºó¾Æµ¿º´¿ø ½ÉÀå¼ö¼úÁö¿ø °ü¸®ÀÚ2014.11.03.4200
148 Á¦46Â÷ ´ëÇÑÈäºÎ½ÉÀåÇ÷°üÇÐȸ Çмú´ëȸ °ü¸®ÀÚ2014.10.27.3746
147 Á¦28Â÷ À¯·´ÈäºÎ¿Ü°úÇÐȸ Çмú´ëȸ °ü¸®ÀÚ2014.10.20.3726
146 Á¦24Â÷ World Congress of WSCTS °ü¸®ÀÚ2014.09.18.3815
145 Ä¯º¸µð¾Æ ÀÇ·áºÀ»ç °ü¸®ÀÚ2014.07.21.3904
144 Á¦ 22Â÷ ¾Æ½Ã¾Æ ½ÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ °ü¸®ÀÚ2014.04.11.4297
RELOAD WRITE
[1] [2] [3] [4] [5] 6 [7] [8] [9] [10]  ¢º 22